ThompsonAJBanwellBLBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. Epub ahead of print 21December2017. DOI: 10.1016/S1474-4422(17)30470–2.
2.
KesselringJ.Multiple sclerosis. 1st ed. Cambridge: Cambridge University Press, 1997.
3.
RoviraÀWattjesMPTintoréMet al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol2015; 11: 471–482.
4.
Martinez-LapiscinaEHArnowSWilsonJAet al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study. Lancet Neurol2016; 15: 574–584.
5.
Aboulenein-DjamshidianFSerbecicNKristoferitschW.Optical coherence tomography in multiple sclerosis. Lancet Neurol2016; 15: 537–538.
6.
Aboulenein-DjamshidianFKrššákMSerbecicNet al. CROP: The clinico-radiologico-ophthalmological paradox in multiple sclerosis: Are patterns of retinal and MRI changes heterogeneous and thus not predictable?PLoS ONE2015; 10: e0142272.
7.
UlrichJGroebkeW.The optic nerve in multiple sclerosis: A morphological study with retrospective clinicopathological correlations. Neuropathology1983; 3: 149–159.
8.
PuthenparampilMFederleLPoggialiDet al. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis. PLoS ONE2017; 12: e0183957.
9.
TripSASchlottmannPGJonesSJet al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage2006; 31: 286–293.
10.
Di MaggioGSantangeloRGuerrieriSet al. Optical coherence tomography and visual evoked potentials: Which is more sensitive in multiple sclerosis?Mult Scler2014; 20: 1342–1347.
